Skip to main content

Table 3 Clinical and demographic data of the patient cohort used in the Meta-analysis

From: Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasms

  N All Males Females Unknown gender Medulloblastoma ATRT Germinoma Controls Mean age (years) STDEV AGE Mean Age (weeks) STDEV age
Meta-analysis ALL 161         4.15 11.91 226.32 574.91
  MALES 82         3.85 13.76 210.26 663.33
  FEMALES 46         1.09 2.43 76.16 122.39
  UNKNOWN GENDER 32         9.20 14.00 476.79 672.56
  MEDULLOBLASTOMA 19 8 7 4      6.89 4.13 366.95 198.43
  ATRT 8 1 3 4      2.23 2.18 142.95 104.49
  GERMINOMA 12 0 0 12      11.15 3.08 571.00 147.76
  CONTROLS 121 73 36 12      3.04 13.43 169.45 647.52
  FETAL 76 40 32 4 0 0 0 76 0.00 0.00 18.39 3.41
  INFANT 19 15 4 0 1 2 0 16 0.56 0.54 62.67 25.71
  CHILD 40 9 10 21 15 6 9 10 5.82 3.52 315.53 168.84
  ADOLESCENT 6 3 0 3 3 0 3 0 14.07 1.57 711.54 75.34
  ADULT 5 2 0 3 0 0 0 5 56.48 29.58 2746.94 1419.60
  % ALL MALES FEMALES UNKNOWN GENDER MEDULLOBLASTOMA ATRT GERMINOMA CONTROLS     
  ALL 100.00%            
  MALES 50.93%            
  FEMALES 28.57%            
  UNKNOWN GENDER 19.88%            
  MEDULLOBLASTOMA 11.80% 4.97% 4.35% 2.48%         
  ATRT 4.97% 0.62% 1.86% 2.48%         
  GERMINOMA 7.45% 0.00% 0.00% 7.45%         
  CONTROLS 75.16% 45.34% 22.36% 7.45%         
  FETAL 47.20% 24.84% 19.88% 2.48% 0.00% 0.00% 0.00% 47.20%     
  INFANT 11.80% 9.32% 2.48% 0.00% 0.62% 1.24% 0.00% 9.94%     
  CHILD 24.84% 5.59% 6.21% 13.04% 9.32% 3.73% 5.59% 6.21%     
  ADOLESCENT 3.73% 1.86% 0.00% 1.86% 1.86% 0.00% 1.86% 0.00%     
  ADULT 3.11% 1.24% 0.00% 1.86% 0.00% 0.00% 0.00% 3.11%